Form PRE 14A Marker Therapeutics For: 10 March
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Marker Therapeutics Inc (MRKR)
Marker Therapeutics Inc stock price live, this page displays NASDAQ MRKR stock exchange data. View the MRKR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Marker Therapeutics Inc real time stock price chart below.
What Is the Marker Therapeutics Inc Stock Price Today?
The Marker Therapeutics Inc stock price today is 1.320.
What Is the Stock Symbol for Marker Therapeutics Inc?
The stock symbol for Marker Therapeutics Inc is ""MRKR.""
What Stock Exchange Does Marker Therapeutics Inc Trade On?
Marker Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Marker Therapeutics Inc a Good Stock to Buy?
Determining whether Marker Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRKR quote. (ISIN: US57055L2060) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Marker Therapeutics Inc Stock Price Today?
The Marker Therapeutics Inc stock price today is 1.320.
What Is the Stock Symbol for Marker Therapeutics Inc?
The stock symbol for Marker Therapeutics Inc is ""MRKR.""
What Stock Exchange Does Marker Therapeutics Inc Trade On?
Marker Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Marker Therapeutics Inc a Good Stock to Buy?
Determining whether Marker Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRKR quote. (ISIN: US57055L2060) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
Fair Value
An estimate of a Marker Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.250
1.355
52 wk Range
0.810
4.070
MRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Marker Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.2501.355
52 wk Range
0.8104.070
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MRKR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Marker Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.867
Upside
+495.96%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.
Compare MRKR to Peers and Sector
Metrics to compare | MRKR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRKRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −6.1x | −0.5x | |
PEG Ratio | −0.05 | −0.15 | 0.00 | |
Price/Book | 1.3x | 2.6x | 2.6x | |
Price / LTM Sales | 6.2x | 11.7x | 3.1x | |
Upside (Analyst Target) | - | 92.2% | 55.6% | |
Fair Value Upside | Unlock | −2.1% | 8.6% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.867
(+495.96% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.12 / -0.62
Revenue / Forecast
1.23M / --
People Also Watch
FAQ
What Is the Marker Therapeutics (MRKR) Stock Price Today?
The Marker Therapeutics stock price today is 1.320 USD.
What Stock Exchange Does Marker Therapeutics Trade On?
Marker Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Marker Therapeutics?
The stock symbol for Marker Therapeutics is "MRKR."
What Is the Marker Therapeutics (MRKR) Afterhours Price Today? (Afterhours variable test: 1.350) Current Date: Mar 20, 2026
After hours price: 1.350. After hours price change (units): 0.030. Price change percentage: 2.270%
What Is the Marker Therapeutics Market Cap?
As of today, Marker Therapeutics market cap is 22.010M USD.
What Is Marker Therapeutics's Earnings Per Share (TTM)?
The Marker Therapeutics EPS (TTM) is -0.794.
From a Technical Analysis Perspective, Is MRKR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Marker Therapeutics Stock Split?
Marker Therapeutics has split 5 times.
How Many Employees Does Marker Therapeutics Have?
Marker Therapeutics has 5 employees.
What is the current trading status of Marker Therapeutics (MRKR)?
As of Mar 20, 2026, Marker Therapeutics (MRKR) is trading at a price of 1.320 USD, with a previous close of 1.320 USD. The stock has fluctuated within a day range of 1.250 USD to 1.355 USD, while its 52-week range spans from 0.810 USD to 4.070 USD.
What Is Marker Therapeutics (MRKR) Price Target According to Analysts?
The average 12-month price target for Marker Therapeutics is 7.867 USD, with a high estimate of 10 USD and a low estimate of 5.6 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +495.96% Upside potential.
What Is the MRKR After Hours Price?
MRKR's last after hours stock price is 1.350 USD, the stock has decreased by 0.030, or 2.270%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.